Paxil maker GlaxoSmithKline has agreed to pay several states $14 million to settle allegations that it blocked generic forms of Paxil, causing patients in those states to pay higher prices. GlaxoSmithKline was charged with filing frivolous patent-infringement lawsuits to allow it to extend Paxil's patent and thus keep generic versions of the drug off the market.
Read moreWhen I first saw the ads for Out and About with Allergies by Zagat, I was really excited. The Zagat guide is going to take on allergies... Read more »
Apologies if the title startled you, but last week, some headlines that shared this or similar sentiments, were splashed over newspapers... Read more »
The selective serotonin reuptake inhibitor (SSRI) category of drugs have been on the scene for over 20 years since it was discovered that... Read more »
There are a number of different medications that are currently used to treat anxiety disorders. Antidepressants, although originally intended to... Read more »
The U.S. Food and Drug Administration has approved a new generic version of the painkiller Relafen. The generic form of the drug, nabumetone, is... Read more »
The Wall Street Journal is reporting that a government investigation into the antidepressant Paxil is widening. The U.S. Department of Justice is... Read more »
The families of two teens who attempted suicide while taking Paxil have filed a class-action lawsuit against GlaxoSmithKline, maker of Paxil. Among... Read more »
The U.S. Supreme Court has upheld a lower court's ruling that Paxil does not deserve patent protection against generic formulas. GlaxoSmithKline... Read more »